Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.

Neurobiology of aging - 1 Dec 2011

Mayeux Richard, Schupf Nicole

Abstract excerpt

Identifying a biomarker for Alzheimer's disease that can be obtained from a blood sample has been a goal of researchers for many years. Over the past few years a number of investigators have studied several plasma biomarkers but most frequently plasma amyloid beta (Aβ)40 and Aβ42 while others have explored the use of genetic variants as biomarkers for diagnosis or risk. This review considers the cross-sectional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Amyloid beta-Peptides
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Peptide Fragments

Share to Presenilin-1

Share to Presenilin-2

Source

Open in PubMed Open full text

Identifiers

PMID: 22078169
DOI: 10.1016/j.neurobiolaging.2011.09.004
PMCID: PMC3233700

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.PMID 22078169Read ↗

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s diseaseSemantic proximity Read ↗

Genetic architecture of plasma Alzheimer disease biomarkersSemantic proximity Read ↗

Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read ↗

Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's DiseaseSemantic proximity Read ↗

Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer's disease and other neurodegenerative dementias.Semantic proximity Read ↗

Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real‐world population‐based cohortSemantic proximity Read ↗

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”Semantic proximity Read ↗

The heritability of blood‐based biomarkers related to risk of Alzheimer's disease in a population‐based sample of early old‐age menSemantic proximity Read ↗

Plasma amyloid β levels are driven by genetic variants near <i>APOE, BACE1, APP, PSEN2:</i> A genome-wide association study in over 12,000 non-demented participantsSemantic proximity Read ↗

Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome‐wide association study in over 12,000 non‐demented participantsSemantic proximity Read ↗

Potential Peripheral Biomarkers for the Diagnosis of Alzheimer′s DiseaseSemantic proximity Read ↗

Definition of a threshold on the plasma Aβ42/Aβ40 ratio measured by single-molecule array to predict the amyloid status of individuals without dementiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.